SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001628280-21-017225
Filing Date
2021-08-18
Accepted
2021-08-18 12:21:16
Documents
1
Period of Report
2021-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_162930366124028.html 4/A  
1 FORM 4/A wf-form4a_162930366124028.xml 4/A 4044
  Complete submission text file 0001628280-21-017225.txt   5545
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030
Business Address
Fair Richard A. (Reporting) CIK: 0001695851 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36783 | Film No.: 211186157